CRISPR-Cas9 is a gene-editing technology that lets scientists target specific DNA sequences and change them with high precision. It matters in medicine because many diseases begin with errors in DNA, the instructions cells use to make proteins. By cutting DNA at a chosen location, CRISPR can help researchers disable harmful genes, repair mutations, or add useful genetic information.
This makes it a powerful tool for studying disease and developing new treatments.
Understanding Medical Technology: CRISPR Gene-Editing Tools
CRISPR came from a natural defence system used by bacteria. Bacteria can store small pieces of virus DNA after an infection. These pieces help them recognise the same virus later.
Scientists adapted this system for laboratory work. The targeting protein does not inspect every DNA letter equally. It first looks for a short nearby marker called a PAM.
Only when that marker is present can it closely test the neighbouring DNA. This extra requirement reduces some accidental matches, though it does not make editing perfectly exact.
The cut is only the start of an edit. A cell treats broken DNA as damage that needs urgent repair. One repair route quickly joins the loose ends together.
This process often loses or adds a few DNA letters. If this happens inside a gene, the gene may stop making a working protein. Researchers use this result when they want to switch off a gene.
A second route can copy information from a supplied DNA template. It can make a planned correction, but it usually works less often and is most active in cells that are dividing.
Getting the editing tools into the right cells is one of the hardest parts of medical use. For some blood disorders, doctors can remove blood stem cells from a patient, edit them in a lab, test the cells, then return them to the body. This is called ex vivo editing.
Other treatments aim to edit cells inside the body, called in vivo editing. They may use tiny fatty particles or altered viruses to carry the instructions.
Different organs take up these delivery systems differently. A treatment that reaches liver cells well may not reach brain cells or muscle cells well.
Scientists measure more than the number of cells that receive an edit. They check whether the intended DNA change happened, whether both copies of a gene changed, and whether the edited cells still work normally. They search for off target edits at similar DNA sequences elsewhere in the genome.
A rare unwanted change can still matter if it affects a gene involved in cell growth. Researchers must also consider immune reactions to the delivery vehicle or the editing protein. Long term follow up is important because some effects may take years to appear.
When learning this topic, separate a change in one cell from a change passed to future generations. Most medical research focuses on body cells, so the edits affect only the treated person. Editing eggs, sperm, or embryos could affect later generations and raises much larger ethical concerns.
It is useful to connect the biology to real decisions about safety, consent, cost, and fair access. A successful edit is not automatically a successful treatment. Doctors need evidence that it improves health without causing unacceptable harm.
Key Facts
- CRISPR-Cas9 uses a guide RNA to locate a matching DNA sequence.
- Cas9 is an enzyme that cuts both strands of DNA at the target site.
- A 20 base guide sequence can target a matching 20 base DNA region.
- DNA base pairing rules are A pairs with T, and C pairs with G.
- Edit efficiency = edited cells / total treated cells.
- After cutting, cells repair DNA by nonhomologous end joining or homology-directed repair.
Vocabulary
- CRISPR
- CRISPR is a gene-editing system adapted from bacterial defenses that can be programmed to target specific DNA sequences.
- Cas9
- Cas9 is a DNA-cutting enzyme that acts like molecular scissors when guided to a target sequence.
- Guide RNA
- Guide RNA is a short RNA molecule designed to match the DNA sequence that scientists want Cas9 to find.
- PAM sequence
- A PAM sequence is a short DNA pattern near the target that Cas9 must recognize before it can cut.
- Homology-directed repair
- Homology-directed repair is a DNA repair process that can copy a provided template to make a precise genetic change.
Common Mistakes to Avoid
- Thinking CRISPR automatically fixes every mutation, which is wrong because Cas9 mainly makes a cut and the cell repair process determines the final edit.
- Ignoring the PAM sequence, which is wrong because many Cas9 enzymes cannot bind or cut DNA unless the correct PAM is next to the target.
- Assuming guide RNA can be any length, which is wrong because target matching usually depends on a designed guide region of about 20 bases for Cas9 systems.
- Confusing gene editing with changing every cell in the body, which is wrong because medical editing usually reaches only treated cells or tissues.
Practice Questions
- 1 A CRISPR treatment is applied to 50,000 cells, and 12,500 cells show the intended edit. Calculate the edit efficiency.
- 2 A guide RNA target region is 20 bases long. If 18 bases match the DNA target and 2 bases do not match, what fraction of the guide matches the target?
- 3 Explain why a CRISPR-Cas9 tool needs both a guide RNA and a Cas9 protein to edit DNA accurately.